21054 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors from animals; from humans
Prevention and reduction of blood loss
#602Compositions and Methods to Inhibit HPV Infection
#603FORMULATIONS OF LIQUID STABLE ANTITHROMBIN
#604C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
#605ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#606METHOD OF PREVENTING FIBRIN CLOTS IN PULMONARY TISSUE THROUGH THE USE OF AEROSOLIZED ANTICOAGULANTS
#607ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#608METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE
#609Treatment of conditions related to cecal ligation shock
#610PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES
#611Method and compositions for prevention and treatment of diabetic and aged skin
#612COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS
#613METHODS AND COMPOSITIONS FOR MODIFYING T CELL IMMUNE RESPONSES AND INFLAMMATION
#614Methods and compositions for oral administration of proteins
#615SERPIN DRUGS FOR TREATMENT OF HIV INFECTION AND METHOD OF USE THEREOF
#616METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#617Identification and characterization of cancer stem cells and methods of use
#618Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome
#619Alpha-1-antitrypsin compositions
#620Treatment of conditions related to shock
#621Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract
#622ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#623Treatment of Menorrhagia with Aromatase Inhibitor
#624Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
#625Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions
#626PLASMIN-INHIBITORY THERAPIES
#627PLASMINOGEN ACTIVATOR INHIBITOR AMELIORATION OF NEWBORN HYPOXIC ISCHEMIC BRAIN INJURY
#628Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract
#629Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#630Compositions and methods for treating ophthalmic disorders
#631PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN
#632Stimulation of neuron regeneration by secretory leukocyte protease inhibitor
#633Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
#634Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue
#635Anti-angiogenic nanoparticle compositions
#636Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
#637MODULATORS OF HYPERSENSITIVITY REACTIONS
#638Tissue kallikrein for the treatment of diseases associated with amyloid protein
#639Methods for the treatment or prevention of hemorrhagic conditions
#640Compositions, methods and uses for inhibition and/or treatment of influenza infection
#641Nucleic acids encoding genetically modified tissue factor pathway inhibitor (TFPI) and method of making the same
#642Chemorepulsion of cells
#643COMPOSITIONS AND METHODS FOR REGULATING COLLAGEN AND SMOOTH MUSCLE ACTIN EXPRESSION BY SERPINE2
#644Treatment of Conditions Related to Shock
#645Muller Cell Specific Gene Therapy
#646PREPARATION OF VIRALLY INACTIVATED BIOLOGICAL FLUIDS HAVING HIGH ALPHA-2-ANTIPLASMIN ACTIVITY
#647Technology for Preparation of Macromolecular Microspheres
#648Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
#649Compositions, methods and uses for inhibition and/or treatment of influenza infection
#650Compositions comprising physiologic concentrations of cytokines
#651Composition And Methods Involving Thrombolytic Agents
#652COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS
#653Methods and compositions for treatment of ocular neovascularization and neural injury
#654METHODS FOR PROMOTING HAIR GROWTH
#655Solid fibrinogen preparation
#656METHODS OF DIAGNOSING, TREATING, AND PREVENTING INCREASED VASCULAR PERMEABILITY
#657Compositions containing α-1-antitrypsin and methods for use
#658METHOD OF TREATING RESPIRATORY DISORDERS
#659Cellular factor-containing solution compositions
#660USE OF FIBRINOGEN AS A PROPHYLACTIC TREATMENT TO PREVENT BLEEDING DURING AND AFTER SURGERY AND AS A BIOMARKER TO IDENTIFY PATIENT WITH AN INCREASED RISK FOR EXCESSIVE BLEEDING AND BLOOD TRANSFUSION
#661Glycopegylation methods and proteins/peptides produced by the methods
#662USE OF THE PEDF FACTOR TO INDUCE CELL REGENERATION
#663KALLIKREIN-INHIBITOR THERAPIES
#664Alpha1 proteinase inhibitor peptides methods and use
#665COMPOSITIONS AND METHODS FOR INCREASING SERUM ANTIOXIDANT CONCENTRATIONS, DECREASING SERUM TRIGLYCERIDE LEVELS, INHIBITING INSULIN-RECEPTOR SIGNALING ACTIVITY, INCREASING SERUM GHRELIN LEVELS, AND DECREASING SERUM TNF-ALPHA LEVELS
#666Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
#667VASCULAR RESTENOSIS PREVENTING AGENT AND IMPLANTABLE INTRAVASCULAR DEVICE COATED THEREWITH
#668PULMONARY DELIVERY OF ALPHA-1 PROTEINASE INHIBITOR
#669USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME
#670Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions
#671INHIBITION OF CALPAIN REDUCES ALLERGIC INFLAMMATION
#672Proteins for use in diagnosing and treating infection and disease
#673Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
#674Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#675Compositions and Methods For Treating Bone Formation Disorders
#676METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#677Kallikrein Inhibitors and Anti-thrombolytic Agents and Uses Thereof
#678Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#679Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#680Biomarkers and therapeutics targets for cognitive decline
#681Elastase inhibitor and acute leukemia
#682COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS
#683Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#684Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#685Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#686Treatment of lung disorders
#687METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#688REGULATION OF CYTOKINE SYNTHESIS AND RELEASE
#689Use of TFPI to Treat Severe Bacterial Infections
#690Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
#691rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetes
#692Anti-cancer agent comprising protein C inhibitor
#693Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity
#694USE OF FIBROUS TISSUE INDUCING PROTEINS FOR HERNIA REPAIR
#695Uses of antileukoprotease in carcinoma
#696Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases
#697INHIBITORS OF SERINE PROTEASE ACTIVITY AND THEIR USE IN METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#698KALLIKREIN-INHIBITOR THERAPIES
#699Glue composition for lung volume reduction
#700Potentiation of anticancer agents
#701Prevention and reduction of blood loss
#702METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING PREMATURE RAPTURE OF FETAL MEMBRANES, RIPENING OF UTERINE CERVIX AND PRETERM LABOR IN MAMMALS
#703Antimicrobial peptides with heparin binding activity
#704Use of epi-hne 1-4
#705ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#706Kallikrein-Inhibitor Therapies
#707Novel cellular factor-containing solution compositions
#708Therapy for primary and metastatic cancers
#709Treatment of cellular proliferative disorders
#710Disease treatment via antimicrobial peptides or their inhibitors
#711Assay
#712Materials and methods for treating ocular-related disorders
#713ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#714Medicament containing activated antithrombin III
#715Anti-PCI antibody for regulating liver regeneration/repair
#716METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#717C-1 Inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
#718Antibody against a human ADAM protease
#719Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions
#720Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
#721Chondrogenic Compositions and Methods of Use
#722Protease Inhibitors For the Treatment of Digestive Pathologies
#723Treatment of Severe Community-Acquired Pneumonia by Administration of Tissue Factor Pathway Inhibitor (Tfpi)
#724Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway Inhibitor
#725Inhibition of Bradykinin Release
#726Infant Nutrition With Protease Inhibitor
#727Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
#728Method of inducing and maintaining neuronal cells
#729Methods and compositions for treating diabetes
#730PREVENTION AND REDUCTION OF BLOOD LOSS
#731Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII
#732Method Of Inducing Apoptosis In Lymphoid Cells
#733Use of Dm43 and Its Fragments as Matrix Metalloproteinases Inhibitor
#734Kallikrein-Inhibitor Therapies
#735Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#736Identification and molecular characterisation of proteins, expressed in the salivary glands
#737METHODS OF TREATING PNEUMONIC PLAGUE
#738CHEMOREPULSION OF CELLS
#739Glutamate Receptor Antagonists as Neuroprotectives
#740Conjugates of a Polymer and a Protein Linked by an Oxime Group
#741Prevention and reduction of blood loss
#742Methods and compositions for the disruption of biofilms
#743Pharmaceutical Compositions Preparation of Peptides, Secreted by the Snake Venom Glands, Particularly of Bothrops Jararaca, Vasopeptidases Inhibitors, Evasins, Their Analogues, Derivatives and Products Associated, Thereof, for Development of Applications and Use in Chronic-Degenerative Diseases
#744Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells
#745Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#746Methods and compositions for treatment of ocular neovascularization and neural injury
#747Methods of treatment involving the protease for activating clotting factor VII
#748Inhibition of invasive remodelling
#749Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
#750ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#751SUPPRESSION OF INHIBITORS
#752METHOD OF TREATING SIDE EFFECTS INDUCED BY THERAPEUTIC AGENTS
#753PREVENTION AND REDUCTION OF BLOOD LOSS
#754Kallikrein-inhibitor therapies
#755Selective induction of apoptosis to treat ocular disease by expression of PEDF
#756Prevention and Reduction of Blood Loss
#757Cardiovascular compositions and methods using combinations of anti-platelet agents
#758Methods and Compositions for Repairing Common Peroneal Nerve Lesions
#759Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein C Inhibitors
#760Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation
#761Composition And Method For Treating Inflammatory Diseases Using Protease Inhibitors
#762Composition for treating a fibrotic disorder comprising an inhibitor of a BMP-1-like protein
#763Prevention and reduction of blood loss
#764Broad specturm anti-viral therapeutics and prophylaxis
#765METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#766Prevention and reduction of blood loss
#767Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
#768Regulation of Cytokine Synthesis and Release
#769Alkaline phosphatase compositions to reduce skin cancer
#770ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#771Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
#772Compounds useful in treating diabetic microvascular complications and age-related macular degeneration
#773ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#774C-1 inactivator inhibits two-chain urokinase mutant and limits hemostatic bleeding during thrombolysis
#775C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
#776Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
#777Methods of treatment for meconium aspiration syndrome
#778Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome
#779Compositions capable of facilitating penetration across a biological barrier
#780Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases
#781Compositions and methods for treating ophthalmic disorders
#782Therapeutic agents for low HDL-cholesterolemia
#783Transdiscal administration of high affinity anti-MMP inhibitors
#784Oral Formulations Comprising Bone Morphogenetic Proteins For Treating Metabolic Bone Diseases
#785Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
#786Methods of Using High Affinity Atiii Variants
#787Methods, systems and reagents for tendon and ligament therapy
#788Metalloproteinase inhibitory agent
#789Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
#790Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
#791IDENTIFICATION AND CHARACTERIZATION OF CANCER STEM CELLS AND METHODS OF USE
#792Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions
#793Pharmaceutical Composition Comprising Factor VII Polypeptides and PAI-1 Polypeptide
#794INHIBITORS OF MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE FOR THE TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS
#795Methods for preventing neurological events
#796Methods for modulating angiogenesis
#797Technology for preparation of macromolecular microspheres
#798Novel antimicrobial peptides with heparin binding activity
#799C1 inhibitor with short half-life transient treatment
#800Method of cancer treatment by p53 protein control
#801Compositions capable of facilitation penetration across a biological barrier
#802Haemostatic sprays and compositions
#803Micronized device for the delivery of biologically active molecules and methods of use thereof
#804Method for accelerating the rate of mucociliary clearance
#805COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS
#806Use of fibrous tissue inducing proteins for hernia repair
#807Dry recombinant human alpha 1-antitrypsin formulation
#808Methods and compositions for inhibiting angiogenesis
#809Method for accelerating the rate of mucociliary clearance
#810Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
#811Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof
#812Kallikrein-inhibitor therapies
#813Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments
#814Methods and compositions relating to cystatin C
#815Glycopegylation methods and proteins/peptides produced by the methods
#816Methods and compositions for inhibiting tumor growth and angiogenesis
#817Protein compositions for promoting wound healing and skin regeneration
#818Therapeutic agents for low HDL-cholesterolemia
#819Chondrogenic compositions and methods of use
#820Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
#821Anti-angiogenic compositions and methods of use
#822Anti-angiogenic compositions and methods of use
#823Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
#824Storage and delivery vessel for two-part medicament
#825XIAP therapy
#826Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals
#827Ocular gene therapy
#828Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1- antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds
#829Methods for treatment of pain
#830Fibrin cell supports and method of use thereof
#831Anti-angiogenic compositions and methods of use
#832Cardioprotective agent
#833Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation
#834C1-inh as a drug for treating viruses pathogenic to humans
#835Methods for modulating angiogenesis
#836Method for reducing obstructive hydrocephalus
#837Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury
#838Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors
#839Prevention and reduction of blood loss
#840Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
#841Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder
#842Novel combination of selective factor VIIa and/or factor XIa inhibitors and selective plasma kallikrein inhibitors
#843Modulation of the neuroendoctrine system as a therapy for motor neuron disease
#844Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
#845Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
#846Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
#847Inhibition of bradykinin release
#848Selective induction of apoptosis to treat ocular disease
#849Methods for modulating cell-to-cell adhesion using an agonist of C1INH-type protein activity
#850Fibrin cell supports and methods of use thereof
#851ITI-D1 Kunitz domain mutants as hNE inhibitors
#852Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor
#853Therapeutic agents for low HDL-cholesterolemia
#854Anti-angiogenic compositions and methods of use
#855Method for preventing or treating osteosarcoma
#856Anti-angiogenic compositions and methods of use
#857Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
#858Plasmin-inhibitory therapies
#859Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells
#860Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft
#861Stabilized liquid polypeptide-containing pharmaceutical compositions
#862Stabilized liquid polypeptide-containing pharmaceutical compositions
#863Use of Alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
#864Composition and method for repairing nerve damage and enhancing functional recovery of nerve
#865Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors
#866Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins
#867Treatment of hi-virus infections with oxidised blood proteins
#868Agents for wound healing
#869Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#870Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections
#871Method of reducing viral load
#872Compositions and methods for the treatment or prevention of gallbladder disease
#873Pharmaceutical composition comprising factor VII polypeptide and PAI-1 polypeptide
#874Cutanceous metabolic bio-activator
#875Pharmaceutical compositions comprising combinations of factor VII polypeptides and aprotinin polypeptides
#876Anti-osteolytic therapy involving adiponectin
#877Autologous coatings for implants
#878Intradiscal anti-inflammatory therapy involving autologous adiponectin
#879Pharmaceutical composition comprising factor VII polypeptides and protein C inhibitors
#880Methods for treating and preventing sepsis using modified C1 inhibitor or fragments thereof
#881Glue compositions for lung volume reduction
#882Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#883Lung volume reduction using glue composition
#884Glue composition for lung volume reduction
#885Targeting sites of damaged lung tissue
#886Targeting damaged lung tissue using compositions
#887Lung volume reduction using glue compositions
#888Targeting damaged lung tissue
#889Methods and active substances for protecting organs
#890Methods for inhibiting angiogenesis and or lymphangiogenesis
#891Materials and methods for treating vascular leakage in the eye
#892Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
#893Metalloproteinase inhibitors
#894Method of using recombinant human antithrombin for neurocognitive disorders
#895Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#896Protease inhibition for prevention or treatment of heart failure
#897Method for preventing or treating malignant melanoma
#898Materials and methods for treating ocular-related disorders
#899Methods for modulating angiogenesis via VEGF
#900Anti-angiogenic compositions and methods of use